Long-term Clinical and Echocardiographic Outcomes in Young and Middle-aged Adults Undergoing the Ross Procedure
Publication date
2021-05-01
Authors
Romeo, Jamie L R
Papageorgiou, Grigorios
da Costa, Francisco F D
Sievers, Hans H
Bogers, Ad J J C
El-Hamamsy, Ismail
Skillington, Peter D
Wynne, Rochelle
Mastrobuoni, Stefano
El Khoury, Gebrine
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Importance: There is no ideal valve substitute for young adults requiring aortic valve replacement. Multicenter data supporting use of the Ross procedure with respect to long-term postoperative valve-related mortality and reintervention, as well as function of the autograft and pulmonary homograft, are needed. Objective: To determine the long-term clinical and echocardiographic outcomes in young and middle-aged patients undergoing the Ross procedure. Design, Setting, and Participants: A retrospective multicenter international cohort study with a median follow-up period of 9.2 years was conducted in 5 experienced centers regularly performing the Ross procedure. Consecutive patients aged 18 to 65 years were included by each center between 1991 and 2018. Main Outcomes and Measures: Survival and autograft-related and homograft-related reintervention. Serial echocardiographic measurements of valve function were analyzed using mixed-effects modeling. Results: During the study period, 1431 patients (74.3% men; n = 1063) were operated on at a median age of 48.5 years (mean [SD], 47.7 [9.5]; range, 18.1-65; interquartile range, 42.7-54.0). Implantation techniques were root inclusion in 355 (24.9%), root replacement in 485 (34.0%), and subcoronary implantation in 587 (41.1%). Right ventricular outflow tract reconstruction was performed with homografts in 98.6% (n = 1189) and bioprostheses in 1.4% (n = 17). Ten patients (0.7%) died before discharge. Median follow-up was 9.2 years (13 015 total patient-years). Survival after 10 and 15 years was 95.1% (95% CI, 93.8%-96.5%) and 88.5% (95% CI, 85.9%-91.1%), respectively. Freedom from autograft and homograft reintervention after 15 years was 92.0% and 97.2%, respectively. Late events were autograft endocarditis in 14 patients (0.11% per patient-year), homograft endocarditis in 11 patients (0.08% per patient-year), and stroke in 37 patients (0.3% per patient-year). Conclusions and Relevance: Given its excellent short-term and long-term outcome in young and middle-aged adults in this study, the Ross procedure should be considered in young and middle-aged adults who require aortic valve replacement. Patients should be referred to an experienced center with a program dedicated to the Ross procedure.
Keywords
Adolescent, Adult, Aged, Aortic Valve Disease/surgery, Aortic Valve Insufficiency/surgery, Bicuspid Aortic Valve Disease/surgery, Cardiac Surgical Procedures/methods, Echocardiography, Female, Hospital Mortality, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Pulmonary Artery/transplantation, Pulmonary Valve/transplantation, Retrospective Studies, Survival Rate, Transplantation, Autologous/methods, Young Adult, Taverne, Journal Article, Research Support, Non-U.S. Gov't
Citation
Romeo, J L R, Papageorgiou, G, da Costa, F F D, Sievers, H H, Bogers, A J J C, El-Hamamsy, I, Skillington, P D, Wynne, R, Mastrobuoni, S, El Khoury, G, Takkenberg, J J M & Mokhles, M M 2021, 'Long-term Clinical and Echocardiographic Outcomes in Young and Middle-aged Adults Undergoing the Ross Procedure', JAMA Cardiology, vol. 6, no. 5, pp. 539-548. https://doi.org/10.1001/jamacardio.2020.7434